GLP-1s may not influence Lp(a), but elevated levels indicate the need for intervention
This tool adjusts calorie goals based on activity levels, logged workouts and AI body scan data
Program Overview and Timeline The GLP-1 Bridge program is scheduled to launch on July 1, 2026, and will run through December 31, 2027
Cognitive and neurological research sometimes overlaps with metabolic studies peptides like Semax and Selank are studied for their neuroprotective and anxiolytic properties, and some researchers investigate potential interactions between metabolic hormones and CNS peptide systems
A report by Systematix Institutional Equities dated 2 January pegs the generic semaglutide opportunity across India, emerging markets and regulated markets at over 5,000 crore over the next 12-15 months
However, there are some key differences between the two medications